Canine Congenital Heart Abnormalities – NAVLE Study Guide

Overview and Clinical Importance

Congenital heart disease (CHD) refers to structural cardiovascular abnormalities present at birth that result from abnormal embryonic development. In dogs, the prevalence of CHD is estimated at less than 1%, yet these conditions represent a significant portion of cardiac cases seen in puppies and young dogs. Early detection through recognition of heart murmurs during routine puppy examinations is critical, as many of these conditions are correctable with interventional or surgical treatment when identified early.

The five most common congenital heart defects in dogs, in order of prevalence, are: patent ductus arteriosus (PDA), pulmonic stenosis (PS), subaortic stenosis (SAS), ventricular septal defect (VSD), and tetralogy of Fallot (TOF). Regional differences exist in prevalence, with PDA being most common in North America while aortic stenosis may predominate in some European countries.

Embryology and Pathophysiology

Understanding the embryologic development of the heart is essential for comprehending how congenital defects arise. The heart develops from the cardiogenic mesoderm and undergoes complex folding, septation, and remodeling processes. Defects can occur due to genetic factors, environmental influences, infectious agents, toxicological exposure, or nutritional deficiencies during critical developmental windows.

Classification of Congenital Heart Defects

Pressure Overload Lesions (Concentric Hypertrophy): Stenotic defects such as pulmonic stenosis and subaortic stenosis obstruct normal outflow of blood from the heart. This creates increased resistance that the ventricle must pump against, leading to concentric hypertrophy of the affected chamber. Potential consequences include exercise intolerance, syncope, arrhythmias, myocardial ischemia, and sudden death.

Volume Overload Lesions (Eccentric Hypertrophy): Shunt defects such as PDA and septal defects create abnormal communications between the systemic and pulmonary circulations. The direction of shunting typically follows pressure gradients, with blood flowing from high-pressure to low-pressure areas. Left-to-right shunts recirculate blood through the pulmonary circulation, causing volume overload and eccentric hypertrophy of the left heart chambers.

[Include Image: Figure 1 - Diagram of normal fetal circulation showing the ductus arteriosus and foramen ovale (See Image Source 1)]

Patent Ductus Arteriosus (PDA)

Patent ductus arteriosus is the most common congenital heart defect in dogs, accounting for approximately 25-30% of all congenital cardiac disease. The ductus arteriosus is a normal fetal vessel connecting the pulmonary artery to the descending aorta, allowing blood to bypass the nonfunctional fetal lungs. At birth, rising oxygen tension and falling prostaglandin levels trigger ductal closure, which normally occurs within the first 7-10 days of life. In affected dogs, inadequate smooth muscle in the ductal wall prevents proper closure.

Breed Predispositions

PDA occurs most commonly in small-breed dogs with a strong female predisposition (approximately 3:1 female to male ratio). Predisposed breeds include: Maltese, Pomeranian, Miniature and Toy Poodle, Shetland Sheepdog, Chihuahua, Bichon Frise, Cocker Spaniel, and German Shepherd. A polygenic threshold trait inheritance pattern has been demonstrated in Miniature Poodles.

Pathophysiology

Left-to-Right Shunting PDA (typical): Since aortic pressure exceeds pulmonary artery pressure throughout the cardiac cycle, blood continuously shunts from the aorta through the patent ductus into the pulmonary artery. This creates volume overload of the pulmonary circulation, left atrium, and left ventricle, leading to eccentric hypertrophy and eventually left-sided congestive heart failure. Diastolic runoff through the ductus decreases diastolic blood pressure, creating wide pulse pressure and characteristic bounding pulses.

Right-to-Left Shunting PDA (reverse PDA): In approximately 1-5% of cases, severe pulmonary hypertension develops, causing pulmonary artery pressure to exceed aortic pressure. This reverses shunt direction, delivering deoxygenated blood to the caudal half of the body. This results in differential cyanosis with pink cranial mucous membranes and cyanotic caudal membranes (vulva, prepuce). Chronic hypoxemia triggers erythropoietin release and polycythemia.

Clinical Signs and Physical Examination

[Include Image: Figure 2 - Schematic diagram of Patent Ductus Arteriosus showing left-to-right shunt flow (See Image Source 2)]

Diagnosis

Echocardiography is the gold standard for diagnosis. Findings include visualization of the ductus, continuous turbulent flow in the pulmonary artery on spectral Doppler, left atrial and left ventricular dilatation, and assessment of ductus morphology and size for treatment planning.

Thoracic radiographs typically show left atrial and ventricular enlargement, prominent pulmonary vasculature (overcirculation), and the classic 'triple bump' silhouette on DV view (aortic arch, pulmonary artery bulge, and left auricular appendage).

Treatment and Prognosis

Due to high risk of CHF within the first 1-2 years of life (approximately 70% mortality without treatment), prompt closure is recommended. Treatment options include:

• Transcatheter occlusion: The Amplatz Canine Ductal Occluder (ACDO) is minimally invasive, highly effective (greater than 95% success), and considered standard of care. Procedure-related mortality is approximately 0.6%.
• Surgical ligation: Via left lateral thoracotomy; preferred for very small patients where catheter access is limited. Also highly successful but more invasive.

Prognosis is excellent with early treatment before CHF develops, with median survival approaching 12 years. Dogs with reverse PDA should NOT undergo surgical closure as this will acutely increase pulmonary pressures and is typically fatal.

Pulmonic Stenosis (PS)

Pulmonic stenosis is the second or third most common congenital heart defect in dogs, accounting for approximately 20-34% of cases. It causes obstruction to right ventricular outflow, typically at the valvular level, resulting in pressure overload and concentric hypertrophy of the right ventricle.

Types and Morphology

Type A (typical): Valve leaflets are fused at the commissures but thin and mobile. Creates doming during systole. Normal pulmonary annulus diameter. Responds well to balloon valvuloplasty.

Type B (dysplastic): Valve leaflets are thickened, hypoplastic, and immobile. Often associated with pulmonary annulus hypoplasia (Ao:PA ratio greater than 1.2). Common in brachycephalic breeds. Less responsive to balloon valvuloplasty.

Breed Predispositions

Predisposed breeds include: English Bulldog, French Bulldog, Boxer, Beagle, Boykin Spaniel, Cocker Spaniel, Samoyed, Chihuahua, Scottish Terrier, Miniature Schnauzer, and West Highland White Terrier. English Bulldogs and Boxers are particularly prone to Type B stenosis and aberrant coronary artery anatomy.

Clinical Signs

Many dogs with mild to moderate PS are asymptomatic. Severe cases may present with exercise intolerance, syncope (especially during exertion), ascites (from right-sided CHF), or sudden death. Physical examination reveals a systolic ejection murmur (crescendo-decrescendo) loudest at the left heart base over the pulmonic valve region. Femoral pulses are typically normal.

Severity Classification

Treatment

Balloon valvuloplasty is the treatment of choice for severe valvular PS with Type A morphology. Success is defined as 50% reduction in pressure gradient. Dogs with Type A stenosis have excellent outcomes (approximately 95% survival with symptom resolution). Type B stenosis has less favorable response (approximately 67% success rate).

Beta-blockers (atenolol) may be used alone or in conjunction with valvuloplasty to reduce myocardial oxygen demand and manage arrhythmias. Medical management alone does not reduce stenosis severity.

[Include Image: Figure 3 - Echocardiographic image showing pulmonic stenosis with post-stenotic dilation of the pulmonary artery (See Image Source 3)]

Subaortic Stenosis (SAS)

Subaortic stenosis is the most common form of aortic stenosis in dogs, characterized by a fibrous or fibromuscular ridge or ring in the left ventricular outflow tract (LVOT) just below the aortic valve. Unlike PDA and PS, SAS is progressive during the first 6-12 months of life, meaning a murmur may not be present at the initial puppy examination.

Breed Predispositions

SAS primarily affects large and giant breed dogs. Predisposed breeds include: Golden Retriever, Newfoundland, Rottweiler, Boxer, German Shepherd, German Shorthaired Pointer, Dogue de Bordeaux, Great Dane, and Bullmastiff. Inheritance appears polygenic in most breeds.

Pathophysiology

The subaortic ridge creates fixed obstruction to left ventricular outflow. The left ventricle must generate higher pressures to overcome the obstruction, resulting in concentric hypertrophy. Consequences include: myocardial ischemia from oxygen supply-demand mismatch (outgrowing blood supply), ventricular arrhythmias, sudden death, and secondary aortic regurgitation from high-velocity turbulent jet damaging the valve. Dogs with SAS are also at increased risk for infective endocarditis.

Clinical Signs and Physical Examination

Many dogs with mild to moderate SAS are asymptomatic. Severe cases may develop exercise intolerance, syncope (especially with exertion), sudden death, or rarely left-sided CHF. Physical examination reveals a systolic ejection murmur loudest at the left heart base, often radiating to the right heart base and carotid arteries. Weak femoral pulses are characteristic (unlike PS which has normal pulses).

Severity Classification and Prognosis

Treatment

Beta-blockers (atenolol) are the mainstay of medical management. They reduce myocardial oxygen demand by decreasing heart rate and contractility, prolong diastolic filling time, and may have antiarrhythmic effects. However, they have NOT been definitively shown to improve survival in dogs with SAS.

Cutting balloon valvuloplasty has shown initial promise but long-term results are disappointing with frequent re-stenosis. Open surgical resection is rarely performed due to availability, cost, and morbidity. There is currently no treatment proven to prevent disease progression or significantly improve survival.

Ventricular Septal Defect (VSD)

Ventricular septal defect is an abnormal communication between the left and right ventricles through the interventricular septum. Most canine VSDs occur in the perimembranous region, high in the septum just below the aortic valve. VSDs are common in cats but less frequent in dogs, accounting for approximately 5-10% of canine congenital heart disease.

Pathophysiology

The direction and magnitude of shunting depends on defect size and the pressure gradient between ventricles. Restrictive VSDs (small) limit flow based on the size of the hole itself, maintaining a large pressure gradient. Non-restrictive VSDs (large) allow equalization of pressures between ventricles; flow is then determined by relative pulmonary versus systemic vascular resistance.

Most VSDs produce left-to-right shunting (blood flows from the higher-pressure left ventricle to the right ventricle), causing pulmonary overcirculation and left-sided volume overload. Small restrictive VSDs are often well-tolerated and may even close spontaneously. Large VSDs can lead to CHF or, if pulmonary vascular disease develops, shunt reversal (Eisenmenger syndrome).

Clinical Signs and Physical Examination

Many dogs with small restrictive VSDs are asymptomatic. A holosystolic (regurgitant) murmur is typically heard loudest at the right sternal border. Paradoxically, smaller defects often produce louder murmurs due to higher flow velocity, while large defects with equalized pressures may have soft or absent murmurs.

Diagnosis and Treatment

Echocardiography with color flow Doppler confirms the diagnosis and allows assessment of defect size, shunt direction, and hemodynamic consequences. Treatment depends on severity. Small restrictive VSDs typically require no treatment. Larger defects causing CHF may benefit from medical management or, in select cases, interventional closure with occluder devices.

Tetralogy of Fallot (TOF)

Tetralogy of Fallot is the most common cyanotic congenital heart defect in dogs. It consists of four concurrent abnormalities arising from a single embryologic malformation (abnormal conotruncal septation):

• Pulmonic stenosis: Obstruction to right ventricular outflow
• Ventricular septal defect: Large, typically nonrestrictive
• Overriding (dextropositioned) aorta: Aorta receives blood from both ventricles
• Right ventricular hypertrophy: Secondary to pulmonic stenosis

Breed Predispositions

TOF is hereditary and polygenic in the Keeshond. Other predisposed breeds include English Bulldog and various terrier breeds.

Pathophysiology

The severity of pulmonic stenosis determines the degree of right-to-left shunting. With severe obstruction, right ventricular pressure exceeds left ventricular pressure, and deoxygenated blood shunts from right to left through the VSD, bypassing the lungs and entering systemic circulation through the overriding aorta. This causes generalized cyanosis (unlike differential cyanosis in reverse PDA). Chronic hypoxemia stimulates erythropoietin release, leading to polycythemia with hematocrit values often exceeding 65%.

Clinical Signs

Dogs with TOF typically present at a young age with cyanosis (blue-tinged gums, tongue), severe exercise intolerance, stunted growth, weakness, and collapse. Polycythemia can cause hyperviscosity syndrome with neurologic signs. A systolic murmur is usually present but may be soft or absent if shunting is severe.

Diagnosis

Echocardiography demonstrates all four components: VSD, overriding aorta, RV hypertrophy, and stenotic/malformed pulmonic valve. Contrast echocardiography (bubble study) confirms right-to-left shunting. CBC reveals polycythemia. Radiographs show right heart enlargement with undercirculated lung fields and small pulmonary vessels.

Treatment and Prognosis

Treatment options are limited. Medical management includes beta-blockers, periodic phlebotomy to maintain hematocrit less than 65-68%, and hydroxyurea for bone marrow suppression if needed. Palliative surgery (modified Blalock-Taussig shunt) creates a systemic-to-pulmonary anastomosis to increase pulmonary blood flow. Open surgical repair has been reported but is rarely performed. Median age at cardiac-related death is approximately 23 months.

Differential Diagnosis: Murmur Characteristics